Suppr超能文献

脑肿瘤干细胞:写大病原体假说的癌症干细胞。

Brain tumor stem cells: the cancer stem cell hypothesis writ large.

机构信息

Division of Neurosurgery, Developmental and Stem Cell Biology Program, Arthur and Sonia Labatt Brain Tumor Research Center, Hospital for Sick Children, Toronto, Ontario, Canada.

出版信息

Mol Oncol. 2010 Oct;4(5):420-30. doi: 10.1016/j.molonc.2010.08.001. Epub 2010 Aug 10.

Abstract

Brain tumors, which are typically very heterogeneous at the cellular level, appear to have a stem cell foundation. Recently, investigations from multiple groups have found that human as well as experimental mouse brain tumors contain subpopulations of cells that functionally behave as tumor stem cells, driving tumor growth and generating tumor cell progeny that form the tumor bulk, but which then lose tumorigenic ability. In human glioblastomas, these tumor stem cells express neural precursor markers and are capable of differentiating into tumor cells that express more mature neural lineage markers. In addition, modeling brain tumors in mice suggests that neural precursor cells more readily give rise to full blown tumors, narrowing potential cells of origin to those rarer brain cells that have a proliferative potential. Applying stem cell concepts and methodologies is giving fresh insight into brain tumor biology, cell of origin and mechanisms of growth, and is offering new opportunities for development of more effective treatments. The field of brain tumor stem cells remains very young and there is much to be learned before these new insights are translated into new patient treatments.

摘要

脑肿瘤在细胞水平上通常具有很强的异质性,似乎具有干细胞基础。最近,来自多个小组的研究发现,人类和实验鼠脑肿瘤中都存在细胞亚群,这些细胞亚群具有肿瘤干细胞的功能,可促进肿瘤生长并产生构成肿瘤实质的肿瘤细胞后代,但随后会失去致瘤能力。在人类的胶质母细胞瘤中,这些肿瘤干细胞表达神经前体细胞标记物,并且能够分化为表达更成熟的神经谱系标记物的肿瘤细胞。此外,在小鼠中模拟脑肿瘤表明,神经前体细胞更容易产生完整的肿瘤,从而将潜在的起源细胞缩小为那些增殖潜能更强的罕见脑细胞。应用干细胞概念和方法为脑肿瘤生物学、起源细胞和生长机制提供了新的见解,并为开发更有效的治疗方法提供了新的机会。脑肿瘤干细胞领域还非常年轻,在将这些新的见解转化为新的患者治疗方法之前,还有很多需要学习的地方。

相似文献

1
Brain tumor stem cells: the cancer stem cell hypothesis writ large.
Mol Oncol. 2010 Oct;4(5):420-30. doi: 10.1016/j.molonc.2010.08.001. Epub 2010 Aug 10.
2
Cancer stem cells in nervous system tumors.
Oncogene. 2004 Sep 20;23(43):7267-73. doi: 10.1038/sj.onc.1207946.
3
Cancer stem cells and brain tumors.
Clin Transl Oncol. 2008 May;10(5):262-7. doi: 10.1007/s12094-008-0195-8.
4
Brain tumor stem cells.
Recent Results Cancer Res. 2009;171:241-59. doi: 10.1007/978-3-540-31206-2_14.
5
Characteristics of glioma stem cells.
Brain Tumor Pathol. 2013 Oct;30(4):209-14. doi: 10.1007/s10014-013-0141-5. Epub 2013 Apr 13.
6
Origins and clinical implications of the brain tumor stem cell hypothesis.
J Neurooncol. 2009 May;93(1):49-60. doi: 10.1007/s11060-009-9856-x. Epub 2009 May 9.
7
Brain tumor stem cells: identification and concepts.
Neurosurg Clin N Am. 2007 Jan;18(1):31-8, viii. doi: 10.1016/j.nec.2006.10.014.
8
Stem cells and brain cancer.
Cell Death Differ. 2006 Jan;13(1):5-11. doi: 10.1038/sj.cdd.4401757.
9
Brain tumor stem cells.
Biol Chem. 2010 Jun;391(6):607-17. doi: 10.1515/BC.2010.059.
10
Stem cells and brain cancer.
Exp Cell Res. 2005 Jun 10;306(2):323-9. doi: 10.1016/j.yexcr.2005.03.007. Epub 2005 Apr 14.

引用本文的文献

2
3
Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival.
J Immunother Cancer. 2024 Apr 9;12(4):e008880. doi: 10.1136/jitc-2024-008880.
5
Neuronal differentiation drives the antitumor activity of mitogen-activated protein kinase kinase (MEK) inhibition in glioblastoma.
Neurooncol Adv. 2023 Oct 12;5(1):vdad132. doi: 10.1093/noajnl/vdad132. eCollection 2023 Jan-Dec.
6
Brain network mapping and glioma pathophysiology.
Brain Commun. 2023 Feb 21;5(2):fcad040. doi: 10.1093/braincomms/fcad040. eCollection 2023.
7
Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia.
Front Oncol. 2023 Jan 17;12:1075559. doi: 10.3389/fonc.2022.1075559. eCollection 2022.
8
Non-coding RNAs and glioma: Focus on cancer stem cells.
Mol Ther Oncolytics. 2022 Sep 17;27:100-123. doi: 10.1016/j.omto.2022.09.005. eCollection 2022 Dec 15.
9
Effects of Lovastatin on Brain Cancer Cells.
Cell Transplant. 2022 Jan-Dec;31:9636897221102903. doi: 10.1177/09636897221102903.

本文引用的文献

1
Integrin alpha 6 regulates glioblastoma stem cells.
Cell Stem Cell. 2010 May 7;6(5):421-32. doi: 10.1016/j.stem.2010.02.018.
3
A hierarchy of self-renewing tumor-initiating cell types in glioblastoma.
Cancer Cell. 2010 Apr 13;17(4):362-75. doi: 10.1016/j.ccr.2009.12.049.
4
Marker-independent identification of glioma-initiating cells.
Nat Methods. 2010 Mar;7(3):224-8. doi: 10.1038/nmeth.1430. Epub 2010 Feb 21.
5
Neural stem cell systems: physiological players or in vitro entities?
Nat Rev Neurosci. 2010 Mar;11(3):176-87. doi: 10.1038/nrn2761. Epub 2010 Jan 28.
6
An RNAi screen identifies TRRAP as a regulator of brain tumor-initiating cell differentiation.
Cell Stem Cell. 2010 Jan 8;6(1):37-47. doi: 10.1016/j.stem.2009.11.002.
7
Neuro-oncology: new hope for patients with gliomas.
Lancet Neurol. 2010 Jan;9(1):17-8. doi: 10.1016/S1474-4422(09)70326-6.
9
Separating stem cells by flow cytometry: reducing variability for solid tissues.
Cell Stem Cell. 2009 Dec 4;5(6):579-83. doi: 10.1016/j.stem.2009.11.008.
10
Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes.
EMBO J. 2010 Jan 6;29(1):222-35. doi: 10.1038/emboj.2009.327. Epub 2009 Nov 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验